Question 1

What are the potential benefits and risks of participating in this trial compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Comparing BL-B01D1 With the Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Recurrent Epithelial Ovarian Cancer(PANKU-GYN01) clinical trial (NCT06994195). Contact the study team or your healthcare provider for specific answers.

Question 2

How will the treatment with BL-B01D1 be administered, and what should I expect during the infusion?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Comparing BL-B01D1 With the Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Recurrent Epithelial Ovarian Cancer(PANKU-GYN01) clinical trial (NCT06994195). Contact the study team or your healthcare provider for specific answers.

Question 3

What kind of monitoring will be done during the trial to check my progress?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Comparing BL-B01D1 With the Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Recurrent Epithelial Ovarian Cancer(PANKU-GYN01) clinical trial (NCT06994195). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific side effects I should be aware of with BL-B01D1?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Comparing BL-B01D1 With the Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Recurrent Epithelial Ovarian Cancer(PANKU-GYN01) clinical trial (NCT06994195). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my eligibility for this trial be determined?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Comparing BL-B01D1 With the Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Recurrent Epithelial Ovarian Cancer(PANKU-GYN01) clinical trial (NCT06994195). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects or my condition worsens during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Comparing BL-B01D1 With the Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Recurrent Epithelial Ovarian Cancer(PANKU-GYN01) clinical trial (NCT06994195). Contact the study team or your healthcare provider for specific answers.

What this study is about